Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
N275193-1g | 1g | In stock | $247.90 | |
N275193-5g | 5g | In stock | $1,111.90 | |
N275193-25g | 25g | In stock | $5,001.90 |
Potent L-type Ca 2+ channel blocker
Synonyms | Bio1_001066 | IDI1_000540 | KBio2_006988 | KBio3_002443 | Dagan | SCHEMBL34277 | YC-93 free base | CAS-55985-32-5 | CHEBI:7550 | YC-93 (free base) | Nicardipine (INN) | AKOS001637090 | Cardene (TN) | CZ5312222S | KBio3_000218 | NCGC00015747-04 | NCGC00015 |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Potent L-type Ca 2+ channel blocker. Alters cytochrome P-450 3A (CYP3A4) expression in rat livers. Elastase inhibitor (IC 50 = 16μM in humans and 18μM in rat). Active in vivo and in vitro. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST, CHANNEL BLOCKER |
Mechanism of action | Antagonist of A 3 receptor;Channel blocker of K v1.4 |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Toxic, refer to SDS for further information. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Nicardipine (YC-93 free base) is a calcium channel blocker with an IC50 of 1 μM for blocking cardiac calcium channels. Nicardipine acts as an agent for chronic stable angina and for controlling blood pressure |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
---|---|
INCHI | InChI=1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,24,27H,13-14,16H2,1-4H3 |
InChi Key | ZBBHBTPTTSWHBA-UHFFFAOYSA-N |
Canonical SMILES | CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC |
Isomeric SMILES | CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC |
PubChem CID | 4474 |
Molecular Weight | 479.52 |
PubChem CID | 4474 |
---|---|
ChEBI | CHEBI:507549 |
ChEMBL Ligand | CHEMBL1484 |
DrugBank Ligand | DB00622 |
BindingDB Ligand | 50017085 |
Wikipedia | Nicardipine |
CAS Registry No. | 55985-32-5 |
PEP | nicardipine |
DrugCentral Ligand | 1909 |
GPCRdb Ligand | nicardipine |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2130286 | Certificate of Analysis | Dec 19, 2023 | N275193 |
H2130287 | Certificate of Analysis | Dec 19, 2023 | N275193 |
D2230079 | Certificate of Analysis | Feb 09, 2023 | N275193 |
D2230060 | Certificate of Analysis | Feb 09, 2023 | N275193 |
D2230034 | Certificate of Analysis | Feb 09, 2023 | N275193 |
H2130285 | Certificate of Analysis | Jun 23, 2022 | N275193 |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed |
Precautionary Statements | P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P312:IF SWALLOWED: call a POISON CENTER/doctor/... IF you feel unwell. |